ArticleJMIR bioinformatics and biotechnology2026
Systematic Mining of Bioactive Compounds for Wound Healing From
Article in JMIR bioinformatics and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Plant-derived exosome-like nanovesicles (P-ELNs) effectively deliver bioactive compounds due to their high biocompatibility and low immunogenicity. While liquid chromatography-mass spectrometry (LC-MS) profiles compounds in complex samples, its analysis of large datasets remains limited by traditional methods. Recent advances in large language models (LLMs) and domain-specific systems have enhanced Chinese biomedical data processing and cross-modal pharmaceutical research. Objective: This study aimed to create a multimodal framework of LC-MS combined with DeepSeek models for data mining of compounds with wound-healing properties from exosome-like nanovesicles derived from Cayratia japonica (CJ-ELNs). Methods: LC-MS identified compounds enriched in CJ (n=3) and CJ-ELNs (n=3), and then compounds specifically enriched in CJ-ELNs were filtered via a four-step filtering workflow. The CJ-ELNs-specific compounds were processed by DeepSeek models for screening naturally active compounds with targeted functions of antioxidation, anti-inflammation, anticellular damage, antiapoptosis, wound healing and tissue regeneration, and cell proliferation. Results: A multimodal framework of LC-MS combined with the DeepSeek-DF model was created. With the assistance of artificial intelligence (AI), a total of 46 naturally active compounds derived from CJ-ELNs with targeted functions were identified. Conclusions: A self-designed multimodal framework of LC-MS, combined with DeepSeek models, rapidly and accurately identifies naturally active compounds from CJ-ELNs. This AI-powered system innovatively integrates the traditional analytical technique with modern LLMs, thus greatly favoring data mining of active ingredients in traditional Chinese medicine herbs.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.